Video

Dr. Slomovitz on the Importance of Developing Sequencing Strategies in Endometrial Cancer

Brian M. Slomovitz, MD, discusses the importance of developing sequencing strategies in endometrial cancer treatment.

Brian M. Slomovitz, MD, gynecologic oncology, Broward Health, professor of obstetrics and gynecology, Herbert Wertheim College of Medicine, Florida International University, discusses the importance of developing sequencing strategies in endometrial cancer treatment.

Research regarding sequencing strategies in endometrial cancer has lagged behind compared with ovarian cancer, says Slomovitz.

However, more treatment modalities are available to women with endometrial cancer compared with ovarian cancer, add Slomovitz. Patients with endometrial cancer may receive chemotherapy, radiation, hormonal therapy, immunotherapy, or other biologic agents as part of their treatment regimen.

In the absence of head-to-head data regarding sequencing, treatment considerations should be based on eliciting the best outcome for patients in the first-line setting, as well as optimizing responses from subsequent therapies, concludes Slomovitz.

Related Videos
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University
Brett L. Ecker, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center